ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel immune-related prognostic model and nomogram for breast cancer based on ssGSEA

Li, Linrong; Li, Lin; Liu, Mohan; Li, Yan*; Sun, Qiang*南方医科大学; 中国医学科学院; 中国医学科学院北京协和医院; y
Frontiers in Genetics2023-1-10DOI: 10.3389/fgene.2022.957675
4阅读
引用收藏
分享

摘要

This study aimed to construct an immune-related prognostic model and a nomogram to predict the 1-, 3-, and 5-year overall survival (OS) of breast cancer patients. We applied single-sample gene set enrichment analysis to classify 1,053 breast cancer samples from The Cancer Genome Atlas (TCGA) database into high and low immune cell infiltration clusters. In cluster construction and validation, the R packages "GSVA, " "hclust, " "ESTIMATE, " and "CIBERSORT " and GSEA software were utilized. ImmPort, univariate Cox regression analysis, and Venn analysis were then used to identify 42 prognostic immune-related genes. Eventually, the genes TAPBPL, RAC2, IL27RA, ULBP2, PSMB8, SOCS3, NFKBIE, IGLV6-57, CXCL1, IGHD, AIMP1, and CXCL13 were chosen for model construction utilizing least absolute shrinkage and selection operator regression analysis. The Kaplan-Meier curves of both the training and validation sets indicated that the overall survival of patients in the low-risk group was superior to that of patients in the high-risk group (p < .05). The areas under curves (AUCs) of the model at 1, 3, and 5 years were, respectively, .697, .710, and .675 for the training set and .930, .688, and .712 for the validation set. Regarding clinicopathologic characteristics, breast cancer-related genes, and tumor mutational burden, effective differentiation was achieved between high-risk and low-risk groups. A nomogram integrating the risk model and clinicopathologic factors was constructed using the "rms " R software package. The nomogram's 1-, 3-, and 5-year AUCs were .828, .783, and .751, respectively. Overall, our study developed an immune-related model and a nomogram that could reliably predict OS for breast cancer patients, and offered insights into tumor immune and pathological mechanisms.

学科与关键词

关键词
immuneprognosticmodelbreast cancerssGSEAnomogram
相关
加载中…
  • Immune-related Gene-based Prognostic Signature for the Risk Stratifica-tion Analysis of Breast Cancer
    Su, Dongqing; Lu, Qianzi; Pan, Yi; Yu, Yao; Wang, Shiyuan; Zuo, Yongchun*; Yang, Lei*Current Bioinformatics, 2022, 17(2): 196-205.被引 3
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
  • Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis
    Yu, Yunlin; Dong, Linhuan; Dong, Changjun; Zhang, Xianlin*International Journal of Genomics, 2023, 2023: 1738750.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2023-01-10
卷期
第 13 卷
页码
957675
DOI
10.3389/fgene.2022.957675
成果收录
SCIE
资助标注
CAMS (Chinese Academy of Medical Sciences) Innovation Fund for Medical Sciences (CIFMS) [2022-I2M-CT-B-001]; National High Level Hospital Clinical Research Funding [2022-PUMCH-B-038]

作者

  • L

    Li, Linrong (第一作者)

  • L

    Li, Lin

查看全部 5 位作者收起作者
  • L

    Liu, Mohan

    chinese acad med sci · peking union med coll · peking union med coll hosp

  • L

    Li, Yan (通讯)

    chinese acad med sci · peking union med coll · peking union med coll hosp

  • S

    Sun, Qiang (通讯)

    chinese acad med sci · peking union med coll · peking union med coll hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417